title: Aortic features in Tangier disease and pathogenetic considerations--Part I. Fatty dots and streaks.
abstract: Morphological studies of aortic fatty dots and streaks, and the adjacent normally appearing intima, in a 5 3/4-year-old boy who died of pneumonia, showed several hitherto unreported features. In lesions, lipid vacuoles and/or other cytoplasmic "inclusions" (ultrastructurally considered to present complex forms of lipids) were present on occasion in the endothelium but consistently involved the (intimal) smooth muscle cells (SMC). Similar changes were present in the adjacent intima, but were here less prominent and "tapered off" distally. A moderate number of macrophages also contained cytoplasmic lipids but such cells entirely free of lipid inclusions were observed, too. Most surprisingly, dilated and many cisternae of rough-surfaced endoplasmic reticulum (ER) in the SMC of lesions were associated spatially with cytoplasmic droplets and other forms of lipids. The results of these studies question the generally accepted central role of macrophages as being primarily involved in the pathogenesis of tissue changes in Tangier disease. It is possible that in view of the absence or paucity of high-density lipoproteins (HDL) and alterations of (their) apo A-I and apo A-II (as well as of other lipids), the arterial SMC may be in some way involved in the metabolism of the above substances in this disorder. Support of this tentative (and highly speculative) assumption must await further work utilizing tissues and cells other than those containing macrophages and other derivatives of reticulo-endothelial system.
authors.affiliation: Department of Pathology, University of Western Ontario, London, Canada.
authors.forename: M D
authors.initials: MD
authors.lastname: Haust
mesh_terms: D001011:Aorta / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D016632:Apolipoprotein A-I / Q000378:metabolism*; D016633:Apolipoprotein A-II / Q000378:metabolism*; D001161:Arteriosclerosis / Q000209:etiology* / Q000473:pathology; D002675:Child, Preschool; D006801:Humans; D008075:Lipoproteins, HDL / Q000378:metabolism; D008297:Male; D008854:Microscopy, Electron; D013194:Staining and Labeling / Q000379:methods; D013631:Tangier Disease / Q000150:complications* / Q000378:metabolism / Q000473:pathology
chemical_list: D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D008075:Lipoproteins, HDL